President Biden’s Executive Order and Impact on Pharmaceutical Companies

Arnall Golden Gregory LLP
Contact

On July 9, 2021, President Biden issued an “Executive Order on Promoting Competition in the American Economy.” The Order focuses on antitrust issues and contains provisions directly affecting pharmaceutical companies and pharmaceutical pricing.

The Order states that Americans are paying too much for prescription drugs and healthcare services. It further states that patent laws have been misused to inhibit and delay competition from generic drugs and biosimilars, thus denying Americans access to lower-cost drugs. The Order indicates that the Administration will support aggressive legislative reforms that would lower prescription drug prices, including allowing Medicare to negotiate drug prices.

President Biden’s Order makes clear that the goal of his administration is to have the Department of Justice and the Federal Trade Commission “enforce the antitrust laws fairly and vigorously.” You can expect that the DOJ and the FTC will become more aggressive in antitrust enforcement than the last Administration.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Arnall Golden Gregory LLP | Attorney Advertising

Written by:

Arnall Golden Gregory LLP
Contact
more
less

Arnall Golden Gregory LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.